Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Terri L. Parker"'
Autor:
Eun-Ju Lee, Daniel J. Dykas, Andrew D. Leavitt, Rodney M. Camire, Eduard Ebberink, Pablo García de Frutos, Kavitha Gnanasambandan, Sean X. Gu, James A. Huntington, Steven R. Lentz, Koen Mertens, Christopher R. Parish, Alireza R. Rezaie, Peter P. Sayeski, Caroline Cromwell, Noffar Bar, Stephanie Halene, Natalia Neparidze, Terri L. Parker, Adrienne J. Burns, Anne Dumont, Xiaopan Yao, Cassius Iyad Ochoa Chaar, Jean M. Connors, Allen E. Bale, Alfred Ian Lee
Publikováno v:
Blood Advances, Vol 1, Iss 16, Pp 1224-1237 (2017)
Abstract: Genetics play a significant role in venous thromboembolism (VTE), yet current clinical laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin gene mutation G20210A, or a deficiency of protein C, pr
Externí odkaz:
https://doaj.org/article/c274b1de27734d959984c4c6623722ac
Autor:
Sabrina L. Browning, Yuxin Liu, Terri L. Parker, Noffar Bar, Tara Anderson, Madhav Dhodapkar, Stuart Seropian, Stephanie Halene, Mina L Xu, Ria Syam, Elan Gorshein, Autumn DiAdamo, Ashita Talsania, Wajih Zaheer Kidwai, David H. Witt, Victor Chang, Francesca Montanari, Andrew Lischuk, Wei Wei, Andrew Haims, Natalia Neparidze
Publikováno v:
Blood. 140:7308-7310
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ae925a0a1be51a7d3d6b792fe9cd48f
https://doi.org/10.1182/blood-2022-166325
https://doi.org/10.1182/blood-2022-166325
Autor:
Yuxin Liu, Sabrina L. Browning, Jennifer VanOudenhove, Giulia Biancon, Noffar Bar, Terri L. Parker, Tara Anderson, Madhav Dhodapkar, Stuart Seropian, Stephanie Halene, Mina L Xu, Elan Gorshein, Ashita Talsania, Wajih Zaheer Kidwai, David H. Witt, Victor Chang, Francesca Montanari, Andrew Lischuk, Andrew Haims, Wei Wei, Natalia Neparidze
Publikováno v:
Blood. 140:7086-7087
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ca79f961924646ba1a759f4a28fed1b
https://doi.org/10.1182/blood-2022-168109
https://doi.org/10.1182/blood-2022-168109
Autor:
Natalie S. Callander, Avina K. Singh, Benjamin M. Parsons, Sagar Lonial, S. Vincent Rajkumar, Shaji Kumar, Matthias Weiss, Paul G. Richardson, Terri L. Parker, Robert Z. Orlowski, Alexander R. Menter, Lynne I. Wagner, Jeffrey A. Zonder, Aaron S. Rosenberg, Adam D. Cohen, Xuezhong Yang, Pankaj Kumar, Susanna Jacobus, Kenneth C. Anderson, Prashant Kapoor, Edward A. Faber
Publikováno v:
The Lancet Oncology. 21:1317-1330
Summary Background Bortezomib, lenalidomide, and dexamethasone (VRd) is a standard therapy for newly diagnosed multiple myeloma. Carfilzomib, a next-generation proteasome inhibitor, in combination with lenalidomide and dexamethasone (KRd), has shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e21e924cba37891af07df7f536da6d55
https://doi.org/10.1016/s1470-2045(20)30452-6
https://doi.org/10.1016/s1470-2045(20)30452-6
Autor:
Sagar Lonial, Carol Ann Huff, Thaddeus J. Unger, Lingling Li, Sylvain Choquet, Nizar J. Bahlis, Jatin P. Shah, Yi Chai, Cristina Gasparetto, David S. Siegel, Philippe Moreau, Dan T. Vogl, David Dingli, Rafat Abonour, Ajay K. Nooka, Rachid Baz, Donna E. Reece, Mohamad Mohty, Jesus G. Berdeja, Meletios A. Dimopoulos, Sundar Jagannath, Maria Gavriatopoulou, Robert F. Cornell, Michael Kauffman, Andrew Yee, Ajai Chari, Kai Li, Sharon Shacham, Darrell White, Andrzej Jakubowiak, Sascha A. Tuchman, Joshua Richter, Suzanne Lentzsch, Katja Weisel, Christine Chen, Terri L. Parker, Craig C. Hofmeister
Publikováno v:
Leukemia
Selinexor is an oral, small molecule inhibitor of the nuclear export protein exportin 1 with demonstrated activity in hematologic and solid malignancies. Side effects associated with selinexor include nausea, vomiting, fatigue, diarrhea, decreased ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1f41e14d803098e3182d3b10be84c44
http://europepmc.org/articles/PMC7449872
http://europepmc.org/articles/PMC7449872
Autor:
Sharon Shacham, Jatin P. Shah, Robert F. Cornell, Ajay K. Nooka, Noa Biran, Paul G. Richardson, Mohamad Mohty, Terri L. Parker, Frenzel Laurent, Lingling Li, Monika Engelhardt, David Kaminetzky, Nathalie Meuleman, Thierry Facon, Jagannath Sundar, Joshua Richter, Gabriel Tremblay, Chantal Doyen, David S. Siegel, Martin Schreder, Philip Vlummens, Maria Gavriatopoulou, Michel Delforge, Marc S. Raab, Katja Weisel, Klaus Podar, Luciano J. Costa, Karlin Lionel, Dan T. Vogl, Philippe Moreau, Ravi Vij, David Dingli, Sascha A. Tuchman, Sylvain Choquet, Meletios-Athanasios Dimopoulos, Janis L. Breeze, Gary J. Schiller, James E. Hoffman, Michael Kauffman, Moshe Yair Levy, Patrick Daniele, Ajaj Chari
Publikováno v:
BMC Cancer
BMC CANCER
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC CANCER
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Background Selinexor is an oral, selective nuclear export inhibitor. STORM was a phase 2b, single-arm, open-label, multicenter trial of selinexor with low dose dexamethasone in patients with penta-exposed relapsed/refractory multiple myeloma (RRMM) t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5fc586be000fec12ae8ce1a4e4ceb60
http://europepmc.org/articles/PMC8419947
http://europepmc.org/articles/PMC8419947
Publikováno v:
Leukemialymphoma. 62(11)
The BOSTON trial showed that use of once-weekly selinexor, bortezomib, and dexamethasone (SVd) prolonged progression-free survival compared to twice-weekly bortezomib and dexamethasone (Vd) in patients with relapsed or refractory (R/R) multiple myelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549a0127f0eec3d13658ab360af9993a
https://pubmed.ncbi.nlm.nih.gov/34151696
https://pubmed.ncbi.nlm.nih.gov/34151696
Publikováno v:
Leukemia & Lymphoma. 60:2927-2930
Peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) are rare, heterogeneous non-Hodgkin lymphomas with poor prognoses. Pralatrexate has demonstrated efficacy in T-cell lymphomas; however, mucositis has been reported as the most com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b5faed9b2049db3ce52ce354e600bb
https://doi.org/10.1080/10428194.2019.1612061
https://doi.org/10.1080/10428194.2019.1612061
Autor:
Noffar Bar, Terri L. Parker, Natalia Neparidze, Scott F. Huntington, Kishan Patel, Smith Giri
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(10)
PURPOSE The MAIA trial found that addition of daratumumab to lenalidomide and dexamethasone (DRd) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma, compared with lenalidomide an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6cf89ac47962e37c91892ffd6190d29
https://pubmed.ncbi.nlm.nih.gov/33411586
https://pubmed.ncbi.nlm.nih.gov/33411586
Autor:
Wei Wei, Steven D. Gore, Nikolai A. Podoltsev, Lohith Gowda, Natalia Neparidze, Manoj M. Pillai, David A. Sallman, Amer M. Zeidan, Jan Philipp Bewersdorf, Stuart Seropian, Stephanie Halene, Terri L. Parker, Thomas Prebet, Rory M. Shallis, David M Swoboda
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e828e015370fce2f45f47781c9a29d4
https://pubmed.ncbi.nlm.nih.gov/33551344
https://pubmed.ncbi.nlm.nih.gov/33551344